Skip to content

Deferred Taxes at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-$66.2M-51.1%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
-$94K
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$2.34M+0.6%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$447K+137%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
-$61.1M-346%
Alkermes logo
AlkermesALKS

Segments

By segment

See full
Rare Neurological Diseases$7.2M-38.0%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.99B-14.9%

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxesAndTaxCredits.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s deferred taxes?
Harmony Biosciences Holdings, Inc. (HRMY) reported deferred taxes of -$3.86M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s deferred taxes changed year-over-year?
Harmony Biosciences Holdings, Inc.'s deferred taxes increased by 10.4% year-over-year, from -$4.31M to -$3.86M.
What does deferred taxes mean?
Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.